[New drugs for horses and production animals in 2020].

In 2020, new pharmaceutical drugs and amendments to existing medication uses were introduced in Germany for horses and food-producing animals, including a new inhalant glucocorticoid, an extended use for an anthelmintic medicine, three new active ingredient combinations, several agents in new formulations, and a balanced electrolyte solution.

New Pharmaceutical Agent for Horses

• In 2020, the inhalable glucocorticoid named ciclesonide (marketed under the brand Aservo EquiHaler) was introduced to the German market. Glucocorticoids are a type of medication usually used in treatment of inflammation or immune reactions. This innovation marked the first time an inhaled glucocorticoid has been available for use in horses.

Extended Use of Fenbendazole

• An existing veterinary medicine, the anthelmintic fenbendazole (sold as Gallifen), was approved for extended use. An anthelmintic is a type of drug used to expel parasitic worms from the body. Previously used to target parasites in various animals, fenbendazole has now been cleared for use in treating pheasants. It belongs to the benzimidazole group of compounds known for their worm-expelling capabilities.

New Combinations and Formulations

• Three new combinations of active ingredients were introduced in the market: ketoprofen combined with tilmicosin, ketoprofen paired with tulathromycin, and prednisolone combined with lidocaine. These combinations typically serve to expand treatment options and efficacy in treating various conditions in animals.
• Three drugs – florfenicol, sodium hydrogen carbonate, and prednisolone – were also launched in new pharmaceutical formulations. Different formulations can improve medicine delivery, effectiveness, dosing convenience, and safety.

Other Introductions to the Market

• A drug called fluralaner, which is a systemic ectoparasiticide used to control parasites on animals, was presented with a new packaging size option. Packaging variations can enhance convenience, cost-effectiveness, and environmental impact.
• A balanced crystalloid whole electrolyte solution with a potential base excess (a measure of alkali in a solution) of zero millimoles per litre was also introduced to the market. This type of fluid therapy solution can support hydration and electrolyte balance in animals under various health conditions.